ACIXF (Acarix AB) Cash Flow from Others: $-0.05 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACIXF Acarix AB ACIXF
39 GF Score
Price $0.03
GF Value $0.03
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Acarix AB Cash Flow from Others?

Acarix AB ACIXF +1.12% 39 Cash Flow from Others is $-0.05 Mil as of Jun. 2026. GuruFocus rates ACIXF with a GF Score™ of 39/100 and a GF Value™ of $0.03 (Fairly Valued). The stock has 1 warning sign investors should review.

Acarix AB's cash flow from others for the three months ended in Jun. 2026 was $-0.02 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.05 Mil.

Acarix AB Cash Flow from Others Related Terms

Acarix AB Cash Flow from Others Historical Data

* Premium members only.

The historical data trend for Acarix AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acarix AB Cash Flow from Others Chart

Acarix AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.13 -0.12 0.10 -0.01

Acarix AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.03 0.03 -0.04 -0.02
ACIXF
39GF Score
Acarix AB ACIXF
Cash Flow from Others is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acarix AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

Frequently Asked Questions Learn more about Cash Flow from Others →
What does a Cash Flow from Others of $-0.05 Mil mean?
Acarix AB (ACIXF) has a Cash Flow from Others of $-0.05 Mil as of Jun. 2026. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Acarix AB and its competitors.
Is Acarix AB's Cash Flow from Others too high?
Acarix AB's current Cash Flow from Others is $-0.05 Mil. Overall, Acarix AB has a GF Score™ of 39/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Acarix AB's Cash Flow from Others compare to ABT and SYK?
Acarix AB's Cash Flow from Others of $-0.05 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Others for a Medical Devices & Instruments company?
A good Cash Flow from Others depends on the Medical Devices & Instruments industry context. However, Cash Flow from Others should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Others mean?
A high Cash Flow from Others can signal that a stock is expensive relative to its fundamentals. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Acarix AB and its competitors. Acarix AB's current Cash Flow from Others is $-0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acarix AB stock overvalued right now?
Based on GuruFocus' analysis, Acarix AB (ACIXF) is currently considered Fairly Valued. The stock's GF Value™ is $0.03, compared to a current price of $0.03 — trading 6.7% below its estimated fair value. The current Cash Flow from Others is $-0.05 Mil. Acarix AB's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Others calculated?
Cash Flow from Others is calculated from a company's financial statements. For Acarix AB (ACIXF), the current Cash Flow from Others is $-0.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acarix AB (ACIXF) Overvalued in 2026?

Based on GuruFocus' analysis, Acarix AB stock appears to be undervalued. The current stock price of $0.03 is trading 6.7% below its estimated GF Value™ of $0.03. GuruFocus considers Acarix AB to be Fairly Valued.

Key valuation signals for ACIXF:

  • Cash Flow from Others: $-0.05 Mil
  • GF Value™: $0.03 vs. price of $0.03 (6.7% below fair value)
  • GF Score™: 39/100 with 1 warning sign

No single metric tells the full story. See the ACIXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acarix AB Business Description

Other Exchanges ACARIX:Sweden
Address Hyllie Boulevard 34, Regus Malmo, Malmo, SWE, 215 32
Acarix AB is a Swedish medical technology company that develops solutions for rapid AI-based exclusion of coronary artery disease (CAD). Its CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. Acarix recommends the CADScor System as a first-line diagnostic tool that uses sensitive acoustics and computational processing to analyze coronary blood flow to rule out coronary artery disease (CAD), with a majority certainty at the point of care. Geographically, the company generates maximum revenue from the United States, and the rest from Germany, Sweden, Iraq, and other regions.
39GF Score

Get the complete analysis for ACIXF

Cash Flow from Others is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price
$0.03
GF Value